Online GLP-1 Programs in Delaware
Delaware is one of the few states whose Medicaid covers GLP-1s for weight loss, through prior authorization. In a state with a high obesity burden, that gives qualifying residents a public-payer path most states no longer offer.
Population
1.1M
45th-largest state
Adult obesity
37.9%
2022 BRFSS
Diagnosed diabetes
13.9%
2022 BRFSS
Medicaid (weight loss)
CoveredFrom $129/mo · Ships in 2–4 days · Sponsored
Insurance
Does Delaware Medicaid cover GLP-1s?
Delaware Medicaid covers GLP-1s for weight loss through prior authorization: the state's 2026 preferred drug list has a dedicated obesity-treatment class listing Wegovy and Zepbound as preferred agents, with step-therapy rules (Delaware Medicaid PDL, 2026). That places Delaware among roughly a dozen states covering the obesity indication. GLP-1s for type 2 diabetes are covered separately. A separate 2026 GLP-1 copay change applies to the state employee plan, not Medicaid.
Online Access
Getting a GLP-1 online in Delaware
GLP-1s are not controlled substances, so Delaware allows them to be prescribed via telehealth when a Delaware-licensed clinician (or one with interstate-compact privileges) meets the standard of care. Online programs can serve residents statewide through a Delaware-licensed prescriber.
Compounding
Compounded semaglutide & tirzepatide in Delaware
Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). Delaware adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.
Demand
Where GLP-1 demand is highest in Delaware
About 38% of Delaware adults have obesity and roughly 14% have diagnosed diabetes (Delaware Division of Public Health, 2022), among the higher burdens in the region. Demand centers on Wilmington, part of the Philadelphia metro, and the Dover area. Delaware stands out for covering weight-loss GLP-1s under Medicaid, giving qualifying residents access many neighboring states lack.
Questions
Delaware GLP-1 FAQ
Does Delaware Medicaid cover Wegovy or Zepbound?
Yes, with prior authorization. Delaware's 2026 Medicaid preferred drug list has a dedicated obesity-treatment class listing Wegovy and Zepbound as preferred, with step-therapy rules (Delaware Medicaid PDL, 2026).
Can I get a GLP-1 prescribed online in Delaware?
Yes, by a Delaware-licensed clinician. GLP-1s are not controlled substances, so standard telehealth standard-of-care rules apply.
Is compounded tirzepatide available in Delaware?
Only narrowly. Routine compounding ended after the FDA resolved the shortages in 2025, and Delaware follows the federal rules with no special carve-out.
Compound Guides
The GLP-1s behind these programs
Sources
How we sourced this page
Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.
- 1.Delaware Medicaid — 2026 Preferred Drug List, obesity treatment agents
- 2.The RX Index — Medicaid GLP-1 coverage by state (2026)
- 3.KFF — Medicaid Coverage of and Spending on GLP-1s (Jan 2026)
- 4.Delaware Division of Public Health — obesity and diabetes data (2022)
- 5.Center for Connected Health Policy — state telehealth laws (2025)
- 6.FDA — Compounding policy as GLP-1 supply stabilizes (2025)
Telehealth, no insurance needed
Personalized GLP-1 for Delaware residents
Skip the coverage maze. Yucca Health connects Delaware residents with US-licensed clinicians for personalized GLP-1 treatment, from $129/mo.
See if you qualifySponsored · Affiliate disclosure
Educational information only, not medical or legal advice and not a substitute for a licensed clinician. GLP-1 coverage, telehealth, and compounding rules vary by state and change frequently; verify the current rules for your state before starting treatment. Links to Yucca Health are sponsored. Last reviewed 2026-06-13.